CEROW
CERo Therapeutics Holdings, Inc.
Set alert
0.00 USD 0.00 -5.56%
0.0017 Day range 0.0018
0.0017 52-week range 0.0017
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0018
- Prev close
- 0.0018
- Mkt cap
- 35.88K
- Vol
- 78.00K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0017
- High
- 0.0018
- Forward P/E
- 0.00
- Beta
- -0.46
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- -0.46
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 14.46M
- Total cash
- 3.65M
- Total debt
- 2.15M
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cero.bio
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CEROW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Highbridge Capital Management, LLC. | 9.02% | 829,598 | 6.14K | Sep 29, 2024 |
| Cowen and Company, LLC | 8.02% | 737,168 | 5.46K | Sep 29, 2024 |
| Cantor Fitzgerald, L.P. | 4.80% | 441,048 | 3.26K | Sep 29, 2024 |
| Periscope Capital Inc. | 4.63% | 425,534 | 3.15K | Sep 29, 2024 |
| MMCAP International, Inc. SPC | 4.08% | 375,000 | 2.77K | Sep 29, 2024 |
| Saba Capital Management, L.P. | 3.22% | 295,913 | 2.19K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Merger Fund, The | 0.68% | 62,781 | 464 | Sep 29, 2024 |
| Saba Capital Income & Opportunities Fd | 0.24% | 21,939 | 162 | Jul 30, 2024 |
| Calamos Market Neutral Income Fund | 0.14% | 12,500 | 92 | Oct 30, 2024 |
| RiverNorth/DoubleLine Strategic Opportunity Fund | 0.07% | 6,744 | 49 | Sep 29, 2024 |
| WCM Alternatives Event Driven Fund | 0.06% | 5,078 | 37 | Sep 29, 2024 |
| RiverNorth Opportunities Fd | 0.06% | 5,294 | 39 | Sep 29, 2024 |